Is Avadel Pharmaceuticals PLC (AVDL) a Good Buy in the Drug Manufacturers

Avadel Pharmaceuticals PLC (AVDL) is near the top in its industry group according to InvestorsObserver. AVDL gets an overall rating of 77. That means it scores higher than 77 percent of stocks. Avadel Pharmaceuticals PLC gets a 97 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 100 out of 148 industries.

AVDL has an Overall Score of 77. Find out what this means to you and get the rest of the rankings on AVDL!

See Full AVDL Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 77 means the stock is more attractive than 77 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Avadel Pharmaceuticals PLC Stock Today?

Avadel Pharmaceuticals PLC (AVDL) stock is down -0.82% while the S&P 500 is up 0.88% as of 12:34 PM on Monday, Mar 18. AVDL has fallen -$0.13 from the previous closing price of $15.92 on volume of 122,259 shares. Over the past year the S&P 500 has risen 30.63% while AVDL is up 93.03%. AVDL lost -$2.00 per share the over the last 12 months. Click Here to get the full Stock Report for Avadel Pharmaceuticals PLC stock.